SEC 13F Intelligence

Propel Bio Management, LLC / MIST

Propel Bio Management, LLC’s Milestone Pharmaceuticals In Position

Does Propel Bio Management, LLC own Milestone Pharmaceuticals In (MIST)? Yes — 4.12M shares worth $5M (+3.20% of its 13F portfolio) as of Q1 2026.

Position Value
$5M
Q1 2026
Shares
4.12M
% of Portfolio
+3.20%
Quarters Held
5
currently held

Position History MIST

Reported value by quarter
Q1 ’25: $1MQ1 ’25Q2 ’25: $3MQ2 ’25Q3 ’25: $10MQ3 ’25Q4 ’25: $8MQ4 ’25Q1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.12M$5M+3.20%
Q4 20254.12M$8M+7.10%
Q3 20255.12M$10M+10.26%
Q2 20251.79M$3M+4.22%
Q1 20251.45M$1M+1.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of MIST.